日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study

卡美司群治疗雌激素受体阳性、人表皮生长因子受体2阴性的绝经后原发性乳腺癌患者的药效学:来自随机、术前SERENA-3研究的结果

Robertson, John F R; Gogitidze, Teimuraz; Katashvili, Zaza; Rocha, Juan Enrique Bargalló; Arkania, Ekaterine; Moppett, Iain; Cheung, Kwok-Leung; Nemsadze, Gia; Ajimi, Maxine; Klinowska, Teresa; Lindemann, Justin P O; Mathewson, Alastair; Morrow, Christopher J; Nikolaou, Myria; Scaltriti, Maurizio; Sykes, Andy; Dzagnidze, Giorgi

Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1

卡美司群联合卡帕替尼治疗ER阳性、HER2阴性晚期乳腺癌女性患者:SERENA-1研究结果

Vaklavas, C; Oliveira, M; Armstrong, A C; Moreno, I; Twelves, C; Victoria Ruiz, I; Bermejo de Las Heras, B; Brier, T; Ciardullo, C; Gibbons, L; Jack, T; Klinowska, T; Lindemann, J P O; Mathewson, A M; Maudsley, R; Morrow, C J; Sykes, A; Baird, R D

Open-Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women

一项开放标签研究评估了健康绝经后妇女口服卡美司群制剂的相对和绝对生物利用度以及食物对其的影响

Sykes, Andy; Engman, Helena; Taylor, Nigel; Brier, Tim; Maudsley, Rhiannon; Kirova, Bistra; Mathewson, Alastair M; Bragg, Ryan A; Gränfors, Malin; Gangl, Eric T; Klinowska, Teresa; Li, Yan; Menakuru, Somasekhar R; Roe, Chris; McDermott, John; Lindemann, Justin P O

Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1

卡美司群联合三种全球获批的 CDK4/6 抑制剂治疗 ER+、HER2- 晚期乳腺癌女性患者:SERENA-1 研究结果

Baird, Richard D; Bermejo de Las Heras, Begoña; Ruiz-Borrego, Manuel; Vaklavas, Christos; Moreno, Irene; Oliveira, Mafalda; Armstrong, Anne; Turner, Nicholas; Incorvati, Jason; Twelves, Chris; Ciruelos, Eva; Hamilton, Erika; Patel, Manish R; Kabos, Peter; Ciardullo, Carmela; Klinowska, Teresa; Lindemann, Justin P O; Mathewson, Alastair M; Morrow, Christopher J; Sykes, Andy; Yang, Jincheng; Zhang, Bairu; Victoria, Ivan

CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancer

CAMBRIA-1 和 CAMBRIA-2 III 期试验:卡美司群与标准内分泌疗法治疗 ER+/HER2- 早期乳腺癌

Hamilton, Erika P; Loibl, Sibylle; Bachelot, Thomas; Gnant, Michael; Niikura, Naoki; Park, Yeon Hee; Tolaney, Sara M; Pistilli, Barbara; Rastogi, Priya; Saini, Kamal S; Gioni, Ioanna; Johnston, Simon; Nunes, Raquel; Quintana, Angela; Stuart, Mary; Syta, Emilia; Walding, Andrew; Klinowska, Teresa; Mayer, Ingrid A

Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC

代谢驱动的口服ERα VHL-PROTAC体外/体内分离

Thomas G Hayhow ,Beth Williamson ,Mandy Lawson ,Natalie Cureton ,Erin L Braybrooke ,Andrew Campbell ,Rodrigo J Carbajo ,Azadeh Cheraghchi-Bashi ,Elisabetta Chiarparin ,Coura R Diène ,Charlene Fallan ,David I Fisher ,Frederick W Goldberg ,Lorna Hopcroft ,Philip Hopcroft ,Anne Jackson ,Jason G Kettle ,Teresa Klinowska ,Ulrike Künzel ,Gillian Lamont ,Hilary J Lewis ,Gareth Maglennon ,Scott Martin ,Pablo Morentin Gutierrez ,Christopher J Morrow ,Myria Nikolaou ,J Willem M Nissink ,Patrick O'Shea ,Radoslaw Polanski ,Markus Schade ,James S Scott ,Aaron Smith ,Judith Weber ,Joanne Wilson ,Bin Yang ,Claire Crafter

The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance

新一代口服选择性雌激素受体降解剂卡米泽司群 (AZD9833) 可抑制 ER+ 乳腺癌的生长并克服内分泌和 CDK4/6 抑制剂耐药性。

Mandy Lawson # ,Natalie Cureton # ,Susana Ros # ,Azadeh Cheraghchi-Bashi ,Jelena Urosevic ,Sophie D'Arcy ,Oona Delpuech ,Michelle DuPont ,David I Fisher ,Eric T Gangl ,Hilary Lewis ,Dawn Trueman ,Neha Wali ,Stuart C Williamson ,Jennifer Moss ,Elodie Montaudon ,Heloise Derrien ,Elisabetta Marangoni ,Ricardo J Miragaia ,Sladjana Gagrica ,Pablo Morentin-Gutierrez ,Thomas A Moss ,Gareth Maglennon ,Daniel Sutton ,Radoslaw Polanski ,Alan Rosen ,Jonathan Cairns ,Pei Zhang ,Mònica Sánchez-Guixé ,Violeta Serra ,Susan E Critchlow ,James S Scott ,Justin P O Lindemann ,Simon T Barry ,Teresa Klinowska ,Christopher J Morrow ,Larissa S Carnevalli

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

一项针对晚期实体瘤患者的 I 期研究,旨在探索强效且选择性的 PI3Kβ/δ 抑制剂 AZD8186 的疗效。

Choudhury, Atish D; Higano, Celestia S; de Bono, Johann S; Cook, Natalie; Rathkopf, Dana E; Wisinski, Kari B; Martin-Liberal, Juan; Linch, Mark; Heath, Elisabeth I; Baird, Richard D; García-Carbacho, Javier; Quintela-Fandino, Miguel; Barry, Simon T; de Bruin, Elza C; Colebrook, Steve; Hawkins, George; Klinowska, Teresa; Maroj, Brijesh; Moorthy, Ganesh; Mortimer, Peter G; Moschetta, Michele; Nikolaou, Myria; Sainsbury, Liz; Shapiro, Geoffrey I; Siu, Lillian L; Hansen, Aaron R

Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection

对ER阳性/HER2阴性晚期乳腺癌循环肿瘤细胞基因组改变进行连续监测:精准肿瘤生物标志物检测的可行性

Cani, Andi K; Dolce, Emily M; Darga, Elizabeth P; Hu, Kevin; Liu, Chia-Jen; Pierce, Jackie; Bradbury, Kieran; Kilgour, Elaine; Aung, Kimberly; Schiavon, Gaia; Carroll, Danielle; Carr, T Hedley; Klinowska, Teresa; Lindemann, Justin; Marshall, Gayle; Rowlands, Vicky; Harrington, Elizabeth A; Barrett, J Carl; Sathiyayogan, Nitharsan; Morrow, Christopher; Sero, Valeria; Armstrong, Anne C; Baird, Richard; Hamilton, Erika; Im, Seock-Ah; Jhaveri, Komal; Patel, Manish R; Dive, Caroline; Tomlins, Scott A; Udager, Aaron M; Hayes, Daniel F; Paoletti, Costanza

HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies

HO-1 驱动自噬作为抵抗 HER2 靶向治疗的机制

Natasha Tracey, Helen Creedon, Alain J Kemp, Jayne Culley, Morwenna Muir, Teresa Klinowska, Valerie G Brunton